Growth parameters in HIV-vertically-infected adolescents on antiretroviral therapy in Rio de Janeiro, Brazil

Authors: Buonora, Sibelle1; Nogueira, Susie2; Pone, Marcus Vinicius3; Aloé, Marisa4; Oliveira, Ricardo Hugo1; Hofer, Cristina2

Source: Annals of Tropical Paediatrics: International Child Health, Volume 28, Number 1, March 2008 , pp. 59-64(6)

Publisher: Maney Publishing

Buy & download fulltext article:

OR

Price: $48.00 plus tax (Refund Policy)

Or sign up for a free trial

Abstract:

Background: Growth failure in HIV-infected children is an important factor in either initiating or changing antiretroviral therapy (ART). This study assesses the impact of HIV infection on growth parameters of adolescents who acquired HIV vertically.

Methods: This retrospective, longitudinal study involved adolescents aged 10–20 years with vertically-acquired HIV infection who were followed up in one of the three main referral centres for paediatric HIV/AIDS in Rio de Janeiro, Brazil. Length, weight and variables related to demographic, clinical and laboratory issues were analysed.

Results: 108 subjects were enrolled. Median age was 12.7 years, median duration of follow-up was 97.2 months and 61 (56.5%) were female. The difference between the baseline and final weight Z-scores was −0.31 (p=0.02). Patients with final weight Z-scores ≤ −2 used more ART regimens (average 4.13) than those with Z-scores > −2 (average 2.90, p<0.01) and also had a lower final CD4+ cell percentage — average 19% vs 24% (p<0.01), respectively. The difference between baseline and final-height Z-scores was −0.27 (p<0.01). Several factors were associated with a final-height Z-score ≤ −2: clinical stage C during follow-up (RR 1.60, 95% CI 1.11–2.31), chronic diarrhoea during follow-up (RR 2.02, 95% CI 1.04–3.90), HAART use (RR 1.41, 95% CI 1.16–1.71), number of ART regimens (p<0.01) and final CD4+ cell percentage (p<0.01). In multivariate analysis, presentation in clinical stage C during follow-up was the only significant variable (OR 4.04, 95% CI 1.23–13.28).

Conclusion: Even on HAART, HIV-infected adolescents have lower growth parameters than the normal population and this is associated with a worse prognosis.

Document Type: Research Article

DOI: http://dx.doi.org/10.1179/146532808X270699

Affiliations: 1: Department of Pediatrics, Federal University of Rio de Janeiro, Brazil 2: Infectious Diseases Service, Department of Preventive Medicine, Federal University of Rio de Janeiro, Brazil 3: Department of Pediatrics, Fernandes Figueira Institute, Rio de Janeiro, Brazil 4: Department of Pediatrics, Jesus Municipal Hospital, Rio de Janeiro, Brazil

Publication date: 2008-03-01

More about this publication?
Related content

Tools

Key

Free Content
Free content
New Content
New content
Open Access Content
Open access content
Subscribed Content
Subscribed content
Free Trial Content
Free trial content

Text size:

A | A | A | A
Share this item with others: These icons link to social bookmarking sites where readers can share and discover new web pages. print icon Print this page